22Rv1 is a castration-resistant human prostate carcinoma epithelial cell line that is derived from an androgen-dependent CWR22 xenograft that relapsed during androgen ablation [23]; this cell line also expresses the androgen receptor splice variant AR-V7. This evidence concerns the gene AR and prostate carcinoma.